NCI Events
Featured Event

Cancer Moonshot Seminar Series
The upcoming presentations will showcase research from different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel report. They will inform the community about the progress of Cancer Moonshot-funded projects, provide outreach related to Cancer Moonshot projects, enhance discussions and collaborations related to Cancer Moonshot research, and promote the sharing of data from Cancer Moonshot initiatives.
Need an Event Site?

Upcoming Events
(Displaying 16 out of 16 results)September 2023

CPTAC Scientific Symposium
The virtual Clinical Proteomic Tumor Analysis Consortium (CPTAC) Scientific Symposium will showcase the most current advances in the field of cancer proteogenomics and cancer research by CPTAC investigators. Agenda will include presentations focused on pan-cancer analyses, tumor characterization and clinical translational studies, and data analysis tools. This virtual-only symposium is open to the public and free to attend, but registration is required to receive a link to the event.

Collaborative Cancer Health Economics Research Workshop
The 2nd Collaborative Cancer Health Economics Research Conference will be held virtually on September 26 – 27, 2023 from 1:00-4:30pm ET. The conference will involve stakeholders from non-profit cancer centers and academic institutions to further identify areas of shared interest and collaboration. Through HEROiC, NCI is uniquely positioned to bring together these stakeholders and further these critical activities.

NCI Emerging Technologies Seminar Series
This seminar series will highlight novel technologies that could transform cancer research and clinical care. These virtual monthly seminars will each showcase an innovative technology from an NCI-supported investigator, including the challenges and opportunities of technology development and how the tools can be used to advance cancer research. The seminar occurs at the end of every month on a Tuesday at 2:00pm ET and is held through Zoom.

Cancer Moonshot Seminar Series
The upcoming presentations will showcase research from different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel report. They will inform the community about the progress of Cancer Moonshot-funded projects, provide outreach related to Cancer Moonshot projects, enhance discussions and collaborations related to Cancer Moonshot research, and promote the sharing of data from Cancer Moonshot initiatives.

Fall 2023 NCI Early Drug Development
The NCI CTEP Early Drug Development Meeting is held annually to enhance communication between NCI and the network of ETCTN investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel involved in CTEP funded oncology early drug development (e.g. nurses, statisticians, translational scientist, etc.) The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.
October 2023

2023 Consortium for Cancer Implementation Science (CCIS) Annual Meeting
The 2023 Consortium for Cancer Implementation Science (CCIS) annual meeting will be a hybrid event, held on October 4 - 5, 2023. The annual meeting will feature a variety of presentations and discussion sessions focused on the future of implementation science in cancer. Virtual action group meetings will take place prior to the annual meeting.

2023 NCI Cohort Consortium Annual Meeting
The 2023 Annual Meeting of the NCI Cohort Consortium will be a hybrid event held on October 11 and October 12. The meeting is sponsored by the Division of Cancer Control and Population Sciences (Epidemiology and Genomics Research Program) and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (NCI), with a goal to bring together consortium researchers to discuss emerging science, scientific progress of consortium projects and groups, gaps, and opportunities for collaboration across studies, and ideas for new scientific projects in the consortium.

NCI's Office of Data Sharing Annual Symposium
The government is prioritizing broad data sharing and collaborative team science as a foundational part of all research planning and funding in this digital age. NCI’s Office of Data Sharing is to bring together experts and stakeholders throughout the cancer research community (policymakers, scientists, clinicians, and students across government, academia, industry and advocacy) to learn from one another and explore ways to improve implementation of new data sharing policies for the greatest public benefit.

NCI Alliance for Nanotechnology in Cancer Annual Principal Investigator Meeting
The 2023 NCI Alliance for Nanotechnology in Cancer Annual Principal Investigator Meeting will be held at the NCI Shady Grove facility on October 17-18, 2023. The meeting will gather the Alliance investigators and collaborators to present their recent research results as well as to discuss emerging opportunities in cancer nanotechnology.

40 Years of Cancer Epigenetics Symposium
Please join us for a 1-day symposium hosted by the NCI Division of Cancer Biology on October 20, 2023, commemorating the 40th anniversary of pivotal discoveries that launched the field of cancer epigenetics.
November 2023

Nanomedicine Workshop: Which Cancers to Treat?
The Nanomedicine: Which Cancers to Treat? virtual workshop will be held on November 3, 8, and 17, 2023. This meeting is open to the public and free to attend, but registration is required to access the event virtually.

2023 NIH/FDA Immunology Symposia on Barrier Immunity
The IIG Steering Committee is pleased to announce that the 2023 NIH/FDA Immunology Interest Group Symposia on Barrier Immunity will be held as an in-person meeting at the Natcher Building on the NIH Bethesda Campus. The IIG Symposia will bring together experts in Barrier Immunity from the extramural and intramural Immunology communities and also provide opportunities for trainees to present their studies and to receive valuable feedback. In order to showcase the best of intramural NIH/FDA immunology, we are counting on your active participation to make this year’s workshop successful.

Preparing for Science-Based Non-Traditional Careers
As fellows and staff scientists at the National Cancer Institute, many of you will be exploring and choosing from various science-based career options in the future. The Office of Training and Education (OTE) in the Center for Cancer Training (CCT) is hosting weekly workshops to help participants learn about the various career opportunities that lie outside of independent academic research. Given these may include unfamiliar roles outside of traditional bench science, we have invited guest speakers from various science-based backgrounds to provide information and insight that will help inform decisions about potential future endeavors. For details about course schedule, invited speakers, and program contacts, please visit the PSNC website. Workshops will be on Wednesdays at 3pm starting Sept 20 through Nov 15.

Measures and Methods to Advance the Science of Teaming and Coordination in Cancer Care
The National Cancer Institute’s Healthcare Delivery Research Program is hosting the virtual workshop, Measures and Methods to Advance the Science of Teaming and Coordination in Cancer Care on November 16, 2023. This event brings together cancer control, healthcare delivery, organizational behavior, and teamwork scientists to discuss measurement and methodological approaches that can strengthen the rigor and reproducibility of care delivery research on teamwork and care coordination across the cancer care continuum.

Sallie Rosen Kaplan Postdoctoral Fellowship for Women Scientists in Cancer Research
The Sallie Rosen Kaplan (SRK) Postdoctoral Fellowship for Women Scientists in Cancer Research was established in 2000 through the estate of Sallie Rosen Kaplan.
December 2023

NIH/FDA COVID-19 Research Workshop
The last two and a half years have brought unprecedented changes to the world with the COVID-19 pandemic. In response to this challenge, the scientific community has mobilized on many fronts with advances in vaccines, diagnostics, treatments, pathology, immunology, virology, structural biology, cell biology, epidemiology and many other areas. However, many challenges still remain, particularly in the areas of long-term pathology, treatments, viral variants, and the development of broadly protective vaccines. To help facilitate interactions and highlight work from NIH/FDA investigators, the NIH/FDA COVID-19 scientific interest group is hosting our third workshop for NIH/FDA staff.